Vireo Growth (VREOF) Cash from Investing Activities (2020 - 2026)

Vireo Growth's (VREOF) quarterly Cash from Investing Activities came in at $8.0 million in Q1 2026, up 827.27% year-on-year from $862745.1 in Q1 2025, and up 184.91% quarter-over-quarter from -$9.4 million in Q4 2025.

Vireo Growth (VREOF) Cash from Investing Activities (2020 - 2026) Analysis & Trends

Vireo Growth has disclosed Cash from Investing Activities across 7 years of filings, most recently posting $8.0 million for Q1 2026.

  • Cash from Investing Activities for Q1 2026 came in at $8.0 million, up 827.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $17.9 million (up 318.25% YoY), and the FY2025 annual result was $8.8 million, up 207.71% from the prior year.
  • Cash from Investing Activities came in at $8.0 million for Q1 2026 at Vireo Growth, up from -$9.4 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $34.0 million in Q2 2025 to a low of -$14.8 million in Q3 2025.
  • The 5-year median for Cash from Investing Activities is -$1.1 million (2023), against an average of -$27337.1.
  • Across the five-year window, Cash from Investing Activities tumbled 1423.26% in 2024 and soared 1167.2% in 2025, its largest moves.
  • Vireo Growth's Cash from Investing Activities stood at -$819539.0 in 2022, then surged by 79.11% to -$171183.0 in 2023, then sank by 1423.26% to -$2.6 million in 2024, then slumped by 261.33% to -$9.4 million in 2025, then jumped by 184.91% to $8.0 million in 2026.
  • The last three Cash from Investing Activities figures came in at $8.0 million (Q1 2026), -$9.4 million (Q4 2025), and -$14.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 229.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -87.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 743.70 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -506.20 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -60.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -2.08 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -15.45 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 25.99 Mn
10 Vireo Growth - - 59.30 Mn 8.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 8.00 Mn
Mar 31, 2026 8.00 Mn
Dec 31, 2025 -9.42 Mn
Dec 31, 2025 -9.42 Mn
Sep 30, 2025 -14.76 Mn
Sep 30, 2025 -14.76 Mn
Jun 30, 2025 34.04 Mn
Jun 30, 2025 34.04 Mn
Mar 31, 2025 -1.10 Mn
Mar 31, 2025 -1.10 Mn
Dec 31, 2024 -2.61 Mn
Dec 31, 2024 -2.61 Mn
Sep 30, 2024 -1.29 Mn
Sep 30, 2024 -1.29 Mn
Jun 30, 2024 -3.19 Mn
Jun 30, 2024 -3.19 Mn
Mar 31, 2024 -1.05 Mn
Mar 31, 2024 -1.05 Mn
Dec 31, 2023 -171,183.00
Dec 31, 2023 -171,183.00